Delivery Order SPE2DB20D1109-SPE2DB21FP28J

Award Date 5/26/21
Potential Completion Date 5/27/21
Potential Value $5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,368.12, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.60 firm fixed-price delivery order is for the supply of 4,566,556,083 units of Oxycodone HCl (IR) 5 mg tablets in 100-count bottles, with a completion date of November 27, 2024. AmerisourceBergen is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides 4,555,372,493 units of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA). The $2,257.83 firm fixed-price delivery order has a completion date of November 10, 2021. The contract is not designated as a set-aside. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of oxycodone-acetaminophen 10-325 mg tablets. The $1,024.88 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,479.68 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,564,766,219 units of the prescription drug Oxycodone HCl 5mg tablet. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This federal contract award, valued at $1,884.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,250,443 units of Oxycodone Hydrochloride 5 mg/5 ml oral solution, a pharmaceutical product used for pain management. This is a firm-fixed price delivery order contract that runs through February 13, 2025. No set-aside designation was used for this award....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,814,520 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles, with a total ceiling value of $1,532.87. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 6, 2024. This contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,537.01 firm fixed price delivery order is for 4,563,348,058 units of Oxycodone Hydrochloride 5 mg tablets. This award is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB21FP28J
    Delivery Order

This federal contract award, valued at $5,035.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of 4,553,692,352 units of Oxycodone HCL 5 mg tablets in 100-count bottles. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to supply a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract award does not have a set-aside designation, indicating it was competitively awarded.

Generated 2/27/25, 12:47 PM